Joellen M. Schildkraut

Dr. Joellen M. Schildkraut is a distinguished professor in the Department of Epidemiology at the Rollins School of Public Health at Emory University. With a profound commitment to advancing public health, she is also an integral member of the Cancer Prevention and Control Research Program at the Winship Cancer Institute. Her research is primarily focused on the genetic epidemiology of ovarian, breast, and brain tumors, areas in which she has made significant contributions to the scientific community. Dr. Schildkraut's academic journey has been marked by a relentless pursuit of knowledge and a dedication to understanding the genetic factors that influence cancer development. Her work has been instrumental in identifying genetic markers and risk factors associated with these cancers, providing valuable insights for prevention and treatment strategies. Her research has not only advanced the field of cancer epidemiology but has also paved the way for personalized medicine approaches in oncology. Throughout her illustrious career, Dr. Schildkraut has authored nearly 360 peer-reviewed journal articles, showcasing her expertise and commitment to scientific excellence. Her contributions extend beyond journal publications, as she has also penned numerous book chapters that serve as essential resources for students, researchers, and clinicians alike. Her work is widely recognized and respected, making her a leading figure in the field of cancer epidemiology. In addition to her research, Dr. Schildkraut is a dedicated educator, inspiring the next generation of public health professionals. She is known for her engaging teaching style and her ability to convey complex concepts in a manner that is both accessible and thought-provoking. Her mentorship has been invaluable to many students and colleagues, fostering a collaborative and innovative research environment. Dr. Schildkraut's contributions to the field of epidemiology and cancer research have earned her numerous accolades and recognition from her peers. Her work continues to have a profound impact on public health, and she remains committed to advancing our understanding of cancer through rigorous research and collaboration.